Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1984 Jul;20(1):65–69. doi: 10.1128/jcm.20.1.65-69.1984

Aminoglycoside resistance among blood culture isolates.

P Huovinen, P Grönroos, E Herva, M L Katila, M L Klossner, O V Renkonen, P Toivanen
PMCID: PMC271247  PMID: 6378968

Abstract

A total of 633 blood culture isolates were collected from 1981 to 1982 from seven major Finnish hospitals, including all university central hospitals. Susceptibility of the strains to gentamicin, tobramycin, amikacin, and netilmicin was determined by the Sensititre microtiter procedure. Resistance against any of these agents occurred in 1.3 to 6.5% of all strains studied. In the Turku University Central Hospital, an increased number of tobramycin- and gentamicin-resistant Staphylococcus epidermidis were found; the frequency of strains resistant to tobramycin was 57% and to gentamicin was 29% versus frequencies of 16 and 18%, respectively, which were observed in the other hospitals. An explanation for this might be a change in the use of aminoglycosides in the Turku University Central Hospital; within 3 years, 1979 to 1981, the consumption of tobramycin and amikacin had increased 330 and 290%, respectively, whereas the use of gentamicin had decreased to 24% of that in the beginning of the period. Resistance against tobramycin was mediated by enzymes APH(2")-AAC(6') and ANT(4').

Full text

PDF
65

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Devaud M., Kayser F. H., Huber U. Resistance of bacteria to the newer aminoglycoside antibiotics: an epidemiological and enzymatic study. J Antibiot (Tokyo) 1977 Aug;30(8):655–664. doi: 10.7164/antibiotics.30.655. [DOI] [PubMed] [Google Scholar]
  2. ERICSSON H., TUNEVALL G., WICKMAN K. The paper disc method for determination of bacterial sensitivity to antibiotics. Relationship between the diameter of the zone of inhibition and the minimum inhibitory concentration. Scand J Clin Lab Invest. 1960;12(4):414–422. doi: 10.3109/00365516009065406. [DOI] [PubMed] [Google Scholar]
  3. McDonnell R. W., Sweeney H. M., Cohen S. Conjugational transfer of gentamicin resistance plasmids intra- and interspecifically in Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother. 1983 Jan;23(1):151–160. doi: 10.1128/aac.23.1.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Minshew B. H., Pollock H. M., Schoenknecht F. D., Sherris J. C. Emergence in a burn center of populations of bacteria resistant to gentamicin, tobramycin, and amikacin: evidence for the need for changes in zone diameter interpretative standards. Antimicrob Agents Chemother. 1977 Dec;12(6):688–696. doi: 10.1128/aac.12.6.688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Moellering R. C., Jr, Wennersten C., Kunz L. J., Poitras J. W. Resistance to gentamicin, tobramycin and amikacin among clinical isolates of bacteria. Am J Med. 1977 Jun;62(6):873–881. doi: 10.1016/0002-9343(77)90655-6. [DOI] [PubMed] [Google Scholar]
  6. Phillips I., Eykyn S., King B. A., Jenkins C., Warren C. A., Shannon K. P. The in vitro antibacterial activity of nine aminoglycosides and spectinomycin on clinical isolates of common Gram-negative bacteria. J Antimicrob Chemother. 1977 Sep;3(5):403–410. doi: 10.1093/jac/3.5.403. [DOI] [PubMed] [Google Scholar]
  7. Pitton J. S. Survey of frequency of sensitivity and resistance to aminoglycosides in Switzerland. J Antimicrob Chemother. 1981 Jul;8 (Suppl A):83–87. doi: 10.1093/jac/8.suppl_a.83. [DOI] [PubMed] [Google Scholar]
  8. Pollock H. M., Minshew B. H., Kenny M. A., Schoenknecht F. D. Effect of different lots of Mueller-Hinton agar on the interpretation of the gentamicin susceptibility of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1978 Sep;14(3):360–367. doi: 10.1128/aac.14.3.360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Price K. E., Kresel P. A., Farchione L. A., Siskin S. B., Karpow S. A. Epidemiological studies of aminoglycoside resistance in the U.S.A. J Antimicrob Chemother. 1981 Jul;8 (Suppl A):89–105. doi: 10.1093/jac/8.suppl_a.89. [DOI] [PubMed] [Google Scholar]
  10. Reeves D. S., Holt A., Bywater M. J., Wise R., Logan M. N., Andrews J. M., Broughall J. M. Comparison of sensititre dried microtitration trays with a standard agar method for determination of minimum inhibitory concentrations of antimicrobial agents. Antimicrob Agents Chemother. 1980 Dec;18(6):844–852. doi: 10.1128/aac.18.6.844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Reller L. B., Schoenknecht F. D., Kenny M. A., Sherris J. C. Antibiotic susceptibility testing of Pseudomonas aeruginosa: selection of a control strain and criteria for magnesium and calcium content in media. J Infect Dis. 1974 Nov;130(5):454–463. doi: 10.1093/infdis/130.5.454. [DOI] [PubMed] [Google Scholar]
  12. Smith P. B., Tomfohrde K. M., Rhoden D. L., Balows A. API system: a multitube micromethod for identification of Enterobacteriaceae. Appl Microbiol. 1972 Sep;24(3):449–452. doi: 10.1128/am.24.3.449-452.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Witchitz J. L. Epidemiological aspects of aminoglycoside resistance in France. J Antimicrob Chemother. 1981 Jul;8 (Suppl A):71–82. doi: 10.1093/jac/8.suppl_a.71. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES